Delivery Order SPE2DB22D3004-SPE2DB24FPF29
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,116.32 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4563681046 - GEL-ONE 30 MG/3 ML SYRINGE 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this contract is $1,763.60 and the completion date is March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense, through indefinite delivery...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $10,228.88 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025 for a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for a specialty pharmaceutical product, GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a ceiling value of $3,527.20. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a potential value of $5,290.80 and a completion date of March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. AmerisourceBergen Drug...
- This delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $7,054.40 firm fixed price contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical products to support military treatment programs and facilities. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp has a track record...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,527.20 firm fixed price delivery order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a performance period through April 24, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,473.50 Firm Fixed Price Delivery Order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563515175 GEL-ONE 30 MG/3 ML SYRINGE 3ML. The $7,054.40 order, with a completion date of February 12, 2024, was placed under an existing contract and does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that regularly provides...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical products. The $10,581.60 delivery order has a performance period ending on January 17, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its corporate office, is an experienced prime contractor providing pharmaceuticals...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPF29Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML, a specialty pharmaceutical product. The $3,174.48 award has a completion date of February 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA, delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities. This delivery order is issued under Amerisourcebergen's indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide these critical healthcare materials to the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 2/6/24 |